Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down

MT Newswires Live

07/16

Harmony Biosciences (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.

Analysts polled by FactSet expect $249.5 million.

The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.

Analysts expect $1.01 billion.

In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.

The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.

Harmony will report its Q2 financial results on Aug. 4.

Shares of the company were down more than 1% in premarket activity Thursday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2651442491"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651442491\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651442491?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651442491","market":"us","top_or_hot":-1,"title":"Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.</p><p>Analysts polled by FactSet expect $249.5 million.</p><p>The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.</p><p>Analysts expect $1.01 billion.</p><p>In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.</p><p>The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.</p><p>Harmony will report its Q2 financial results on Aug. 4.</p><p>Shares of the company were down more than 1% in premarket activity Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-16 21:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.</p><p>Analysts polled by FactSet expect $249.5 million.</p><p>The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.</p><p>Analysts expect $1.01 billion.</p><p>In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.</p><p>The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.</p><p>Harmony will report its Q2 financial results on Aug. 4.</p><p>Shares of the company were down more than 1% in premarket activity Thursday.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2651442491","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651442491","pubTimestamp":1784207207,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Harmony Biosciences  reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.Analysts polled by FactSet expect $249.5 million.The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.Analysts expect $1.01 billion.In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.Harmony will report its Q2 financial results on Aug. 4.Shares of the company were down more than 1% in premarket activity Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HRMY":"Harmony Biosciences Holdings, Inc."},"translate_title":"Harmony Biosciences 预计第二季度 Wakix 收入将增加；首席财务官 Glenn Reicin 辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRMY":1},"content_text":"Harmony Biosciences (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.Analysts polled by FactSet expect $249.5 million.The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.Analysts expect $1.01 billion.In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.Harmony will report its Q2 financial results on Aug. 4.Shares of the company were down more than 1% in premarket activity Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}